Skip to main content
Equibles

BI Asset Management Fondsmaeglerselskab A/S

Position in EXEL — Exelixis, Inc.

CIK 1778131 KOBENHAVN, G7
Back to EXEL Full portfolio

Position in EXEL

as of Jun 30, 2026 · filed Aug 10, 2026
Position Value
$14,955,513
+$8,422,509 QoQ
Shares Held
274,867
+80.5% QoQ
Ownership
0.111%
of shares outstanding
% of Portfolio
0.12%
of 13F equity value
Holder Rank
#109
of 756 holders
Holding Since
Mar 2020
10 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in EXEL Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

BI Asset Management Fondsmaeglerselskab A/S holds $75,123,826 across 13 Biotechnology names. EXEL ranks #3 (19.9% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 35,137 $17,453,602
2 HALO
Halozyme Therapeutics, Inc.
 206,563 $16,167,686
3 EXEL
Exelixis, Inc.
This page 		274,867 $14,955,513
4 INCY
Incyte Corp
 113,231 $12,835,866
5 INSM
INSMED Inc
 46,033 $4,908,038
6 REGN
Regeneron Pharmaceuticals, Inc.
 5,132 $3,200,007
7 ALNY
Alnylam Pharmaceuticals, Inc.
 7,097 $2,136,409
8 IONS
Ionis Pharmaceuticals Inc
 25,727 $2,039,893

All Filings in EXEL

Export CSV
10 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $14,955,513 274,867
2026-03-31 $6,533,004 152,320
2025-12-31 $1,913,530 43,658
2025-09-30 $7,177,361 173,786
2025-06-30 $3,389,399 76,892
2025-03-31 $7,857,425 212,823
2024-12-31 $158,274 4,753
2020-09-30 $914,185 37,390
2020-06-30 $887,638 37,390
2020-03-31 $1,258,351 73,075